Endo International

Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Endo Health Solutions Inc. provides specialty healthcare solutions in the United States and internationally. The company’s Endo Pharmaceuticals segment offers branded prescription products,.

DUBLIN, Oct. 6, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced the release of its first Environmental, Social and Governance (ESG) report, titled 2019 Corporate Responsibility Report: Helping Everyone We Serve Live Their Best Life. It summarizes the Company's...

Endo Releases First Environmental, Social and Governance Report

DUBLIN, Oct. 1, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that its subsidiary, Par Pharmaceutical, Inc. (Par), has begun shipping sapropterin dihydrochloride tablets, 100 mg, and powder for oral solution, 100 mg and 500 mg, following final approval from...

Endo Begins Shipment of Generic Kuvan® Tablets and Powder for Oral Solution (sapropterin dihydrochloride)

Endo (ENDP) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Endo (ENDP) Surges: Stock Moves 8.4% Higher

Novavax

Novavax Inc. (NASDAQ: NVAX) said that Endo International (NASDAQ: ENDP) will be in charge of manufacturing its COVID-19 vaccine after the two companies inked a non-exclusive agreement on Friday. Earlier this year in July, the U.S. government invested £1.27 billion in Novavax under its “Operation Warp Speed” program.

Endo International to manufacture Novavax’s candidate COVID-19 vaccine

The two companies signed a manufacturing agreement.

Why Novavax and Endo International Stocks Are Rising Today

DUBLIN, Sept. 25, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that its subsidiary, Par Sterile Products, LLC (Par Sterile) has entered into a non-exclusive agreement with Novavax, Inc. to provide fill-finish manufacturing services at its plant in Rochester,...

Endo Announces Fill-Finish Manufacturing and Services Agreement for Novavax COVID-19 Vaccine Candidate

DUBLIN, Sept. 24, 2020 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) today announced that it will present data relevant to the use of Qwo™ (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women during Vegas...

Endo to Present Qwo™ (collagenase clostridium histolyticum-aaes) Data at Vegas Cosmetic Surgery & Aesthetic Dermatology (VCS)

DUBLIN, Sept. 8, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that it will participate in the Citi 15th Annual BioPharma Virtual Conference being held September 8-10, 2020.

Endo to Participate at Citi 15th Annual BioPharma Virtual Conference

Endo (ENDP) reported earnings 30 days ago. What's next for the stock?

Endo (ENDP) Down 19.5% Since Last Earnings Report: Can It Rebound?

DUBLIN, Aug. 21, 2020 /PRNewswire/ -- Endo International plc (the "Company") (NASDAQ: ENDP) announced today the expiration and final tender results of the previously announced cash tender offer (the "Offer") by its wholly owned subsidiary Endo Finance LLC ("Endo Finance") for any and all.

Endo International plc Announces The Expiration And Final Tender Results Of Its Previously Announced Tender Offer

New York, New York--(Newsfile Corp. - August 18, 2020) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Endo International Plc ("Endo") (NASDAQ: ENDP) between August 8, 2017 and June 10, 2020.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Endo International Plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 18, 2020 - ENDP

Los Angeles, California--(Newsfile Corp. - August 18, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Endo International plc (NASDAQ: ENDP) ("Endo" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S.

DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Endo International plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

New York, New York--(Newsfile Corp. - August 17, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Endo International plc ("Endo" or the "Company") (NASDAQ: ENDP) of the August 18, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.If you invested in Endo stock or options between August 8, 2017 and June 10, 2020 and.

Endo Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Endo International plc To Contact The Firm

LOS ANGELES--(BUSINESS WIRE)---- $ENDP #classaction--The Law Offices of Frank R. Cruz reminds investors of the upcoming August 18, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Endo International plc ("Endo" or "the Company") (NASDAQ: ENDP) securities between August 8, 2017 and June 10, 2020, inclusive (the “Class Period”).

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Endo International plc (ENDP)

New York, New York--(Newsfile Corp. - August 17, 2020) -  Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Endo International plc ("Endo" or the "Company") (NASDAQ: ENDP) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Endo securities between August 8, 2017, and June 10, 2020, both dates inclusive (the "Class Period").

ENDP DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Endo International plc and Lead Plaintiff Deadline: August 18, 2020

Los Angeles, California--(Newsfile Corp. - August 17, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Endo International plc (NASDAQ: ENDP) ("Endo" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S.

DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Endo International plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - August 16, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Endo International plc ("Endo" or "the Company") (NASDAQ: ENDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S.

TUESDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Endo International plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

New York, New York--(Newsfile Corp. - August 14, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Endo International Plc (NASDAQ: ENDP) alleging that the Company violated federal securities laws.Class Period: August 8, 2017 and June 10, 2020Lead Plaintiff Deadline: August 18, 2020Learn more about your recoverable losses in DNK:

ENDP ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 18, 2020 in the Class Action Filed on Behalf of Endo International Plc Limited Shareholders

Los Angeles, California--(Newsfile Corp. - August 13, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Endo International plc (NASDAQ: ENDP) ("Endo" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S.

TUESDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Endo International plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - August 12, 2020) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Endo International plc (NASDAQ: ENDP) ("Endo" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S.

TUESDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Endo International plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

New York, New York--(Newsfile Corp. - August 10, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Endo International plc ("Endo" or the "Company") (NASDAQ: ENDP) of the August 18, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.If you invested in Endo stock or options between Augus

Endo Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Endo International plc To Contact The Firm

Endo International plc's (ENDP) CEO Blaise Coleman on Q2 2020 Results - Earnings Call Transcript

Endo's (ENDP) earnings and sales beat estimates in the second quarter as COVID-19-related restrictions ease out.

Endo (ENDP) Q2 Earnings & Sales Beat as Coronavirus Impacts Ease

— Revenues decreased 2% to $688 million compared to prior year — — On July 6, 2020, U.S. FDA approved Qwo™ (collagenase clostridium histolyticum-aaes), the first injectable treatment for cellulite — DUBLIN, Aug.

Endo Reports Second-Quarter 2020 Financial Results

LOS ANGELES, Aug. 5, 2020 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming August 18, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of Endo International plc ("Endo" or "the Company") (NASDAQ: ENDP) securities.

News for Endo International Stock (ENDP)